Treatment of lymphoma and cardiac monitoring during pregnancy

Abstract

Limited data is available regarding fetal-maternal outcomes with chemotherapy during pregnancy, including cardiovascular toxicity and evaluation thereof. Early cardiovascular evaluation and initiation of cardioprotective therapies should be considered. Herein, we report a case of a 33-year-old woman treated with R-CHOP chemotherapy for large B-cell lymphoma found to have some degree of reversible cardiac strain.

Keywords

• chemotherapy
• R-EPOCH
• R-CHOP
• pregnancy
• cardiotoxicity
• cardiac strain
• lymphoma
• mediastinal mass
• CT scan
• chest x-ray